Summary.-The effect of the growth of two syngeneic transplanted sarcomata of widely differing biological properties on the number of monocytes in the blood of rats was measured (1) by binding of a specific antimacrophage serum to leucocytes, and (2) by sedimenting in a density gradient rosettes between mononuclear cells and antibody-coated sheep red cells under conditions in which B-cells are not brought down. For the 4 syngeneic sarcomata studied there was a progressive increase in the number of monocytes with tumour growth and the values returned to normal a few days after their surgical removal. The extent of monocytosis was related to the immunogenicity of the tumour and was most pronounced for the HSBPA sarcoma, which is highly immunogenic, has a low rate of spontaneous metastasis and contains many macrophages, and least for the MC-3 sarcoma which is essentially non-immunogenic, invariably gives rise to distant metastases and contains only about 8% macrophages. The growth of sarcomata had previously been found to reduce the number of monocytes which enter inflammatory lesions, both non-specific and due to a delayed hypersensitivity reaction. This " antiinflammatory" action of sarcomata which is related to their immunogenicity cannot be ascribed to the preferential uptake of monocytes by the tumours and it is concluded that the monocytes in the blood of tumour-bearers, though increased in number, are modified so that they do not enter sites of inflammation.
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IN a previous study (Eccles and Alexander, 1974a) syngeneic transplanted sarcomata were found to vary widely in the extent to which they reduced the capacity of rats to mount non-specific inflammatory reactions, as well as delayed hypersensitivity responses to antigens unrelated to the tumour. The former was measured by counting the number of macrophages recoverable from the peritoneal cavity 4 days after stimulation with oyster glycogen (in normal rats this produced an increase from 2 to 14 x 106 macrophages per rat). The effect on delayed hypersensitivity was assessed by measuring the degree of swelling of foot pads following injection of either sheep red blood cells (SRBC) or PPD into rats which had been previously sensitized with SRBC or BCG respectively.
A number of tests showed that this " anti-inflammatory " effect of tumour growth was due to a failure of monocytes to extravasate into the sites of inflammation or antigen challenge and was not caused by a reduction in the number of allergized lymphocytes. The intensity of both types of reaction decreased progressively as the tumours grew and returned to normal within 6 days of tumour excision. For a given size of tumour, there was a correlation between the degree of suppression and the macrophage content of the tumour (which for the different sarcomata studied ranged from 3 to 58% of the total cells). Since Evans (1972) had shown that the macrophages in the tumour are of host origin, and as they do not divide in situ they must all be derived from blood monocytes. This suggested that the failure of monocytes to reach sites of inflammation in tumour-bearing rats might be caused by sequestration of the circulating monocytes within the tumour. A corollary of this hypothesis is that the number of circulating monocytes in the blood should fall in parallel with the observed "anti-inflammatory " effects.
Monocytes, unlike their mature counterparts macrophages-cannot always be reliably identified using morphological criteria alone, and the immature forms which tended to appear in the blood of tumour-bearing animals were particularly difficult to distinguish from other early cell types. For this reason two alternative methods, which depend on functional properties were devised to identify blood monocytes:
(1) Membrane fluorescence using a specific rabbit anti-rat macrophage serum (RAMS). (2) Separation by density sedimentation of rosettes formed between monocytes and antibody-coated sheep red cells (EA rosettes). These tests showed that growth of sarcomata induced a marked monocytosis and the " antiinflammatory" action cannot, therefore, be ascribed to the preferential attraction of monocytes to the tumour leading to a depletion of monocytes elsewhere. Consequently, the mechanism whereby monocytes are able to enter tumours but have a reduced capacity to enter sites of inflammation or antigen challenge, has yet to be explained.
MATERIALS AND METHODS
Transplantation, of tumours.-The chemically-induced sarcomata were transplanted by mechanically prepared cell suspenvions into the legs of syngeneic male 10-week-old " hooded " rats. The average macrophage contents of the HSBPA, HSN, MC-1 and MC-3 sarcomata were respectively 54%O, 40%, 38% and 8%. Their biological properties have been described previously (Eccles and Alexander, 1974a, b Assay of rnonocytes by immune fluorescence uwith RAMS.-3 x 106 blood inononuclear cells were placed in siliconized tubes, and 0 5 ml of RAMS at a final dilution of 1: 100 was added, and the mixture incubated at 4°C for 1 h. The cells were then washed twice, goat anti-rabbit serum conjugated with fluorescein (Burroughs Wellcome) added at a dilution of 1: 10, and incubated at 4°C for 1 h. The cells were then washed 3 times in Medium 199, spun down, and resuspended in 2 drops of buffered glycerol. One drop was placed on a slide and mounted under a coverslip. These preparations were examined with a Leitz u.v. microscope and positively stained cells counted. Cells of the monocyte/macrophage series stained positively with this preparation of RAMS under the conditions described. No staining was found with thoracic duct lymph cells, cultured sarcoma cells, leukaemia cells (i.e. the SAL myeloid rat leukaemia or the HRL rat lymphatic leukaemia described by Wrathmell (1976) Hayward (1974) found that rat B-cells appeared as EA rosettes in the pellet of a FicollTriosil gradient. Parish and Hayward, however, used a much higher EA: mononuclear cell ratio (i.e. 10% EA as opposed to 2 o in the procedure used by us), a higher Ficoll-Triosil density (1.09 as opposed to 1-077 g/ml) higher g forces in the separation, and an incubation period of EA and mononuclear cells prior to separation, while in our procedure separation begins immediately after mixing. The two techniques were compared using rat thoracic duct lymph cells which contain B and T lymphocytes but no monocytes. By the Parish and Hayward method, 15% of the thoracic duct cells were spun down as EA rosettes, whereas <2% were pelleted in the procedure used by us. Table I From these experiments we concluded that the procedure described in this paper for sedimenting EA rosettes formed with mononuclear cells from rat blood results in a preparation which contains less than 5% B-cells. The evidence that essentially all of the monocytes were recovered is that in the upper layer less than 1% interacted with RAMS, adhered to glass on culture for 24 h, or phagocytosed EA cells. In toto these data show that the sedimentation technique described, which relies on qualitative differences between EA rosettes of B-cells and monocytes, is capable of providing a method for enumerating the monocytes in the blood of rats. Whether a similar procedure is applicable to all other species remains to be established, although preliminary human data is promising.
Monocytosis associated with tumour growth
The two transplanted syngeneic sarcomata, HSBPA and MC-3, grow at approximately equal rates in the hind limbs of rats following transplantation. The monocyte count in normal rats showed periodic variations and ranged from 0 5 to 1-5 x 105/ml of blood. At the time when this experiment was performed, the number found in the blood of stock rats was in the lower range of 0 5 to 1 0 x 105/ml. The figure shows that both sarcomata induced a progressive monocytosis but this effect was greater with the HSBPA, in which the number of monocytes had increased approximately 8-fold 14 days after transplant when the tumours weighed an average of 15 g.
Two other tumours, HSN and MC-1, with immunogenicities and metastatic capacities between those of HSBPA and MC-3 (Eccles and Alexander, 1974b) , were also tested for their effects on monocyte levels at 10 days after inoculation, and the values obtained were 0-52 x 106 -and 0-46 x 106/ml respectively, which fall between the figures obtained for HSBPA and MC-3 at this stage of growth.
Following surgical removal of the tumour by amputation of the leg, the number of blood monocytes returned to the normal range within 5 days. In control rats, amputation of the leg did not cause the number of monocytes to fluctuate outside the range normally found (i.e. 0-5-1-5 x 105/ml).
Although the EA rosette sedimentation method had been used for the sequential analysis of blood monocytes during tumour growth, it was felt that the values obtained should be checked using an entirely independent assay. For this reason, selected blood samples were also assayed for blood monocytes using the fluorescent RAMS method. The results are shown in Table II , and it can be seen that both methods give closely comparable results.
Infection, particularly with intracellular organisms (Volkman and Collins, 1974) , is known to induce moderate monocytosis in rodents. While infection introduced with the transplant cannot be definitely excluded as the cause for the monocytosis seen in the tumour- 
DISCUSSION
Our observation that the growth of rat sarcomata is accompanied by monocytosis is in agreement with earlier findings that transplanted tumours can stimulate the RE system and increase the number of granulocyte and macrophage precursors in bone marrow (Lappat and Cawein, 1964; Hibberd and Metcalf, 1971; Baum and Fisher, 1972) . The experiments reported were carried out in the hope of elucidating the reasons for the differences in anti-inflammatory action of different sarcomata (Eccles and Alexander, 1974a (Whitelaw, 1966) and therefore to supply the monocytes entering the tumour, their output has to be vastly increased. The bone marrow is clearly capable of responding to this demand since the rat is not monocytopaenic but on the contrary the number of blood monocytes is raised by a factor of up to 8 although this does plateau, implying an upper limit of production. The stimulus may be provided by a factor released from the tumour which acts on the bone marrow or be associated with the immune stimulus provided by the tumour-specific antigens.
The possibility that the difference in the degree of monocytosis induced by the tumours studied here may be related to the immune response of the host appears to find support from a previous study (Eccles and Alexander, 1974b) in which correlations had been observed between the biological properties of different sarcomata and their macrophage content. The two tumours investigated most extensively in the present study represent the extreme ends of the spectrum. The HSBPA contains around 54% macrophages, and following surgical excision after 14 days of growth, only 10% of the rats develop distant metastases. The MC-3 sarcoma has 8% macrophages, and 100% of the rats die within 6 months from distant metastases following removal of the local sarcoma. Immunogenicity-defined by the number of tumour cells which an immunized rat is capable of rejecting-parallels the macrophage content and is inversely related to metastasis, i.e. rats immunized with HSBPA are capable of rejecting more than 107 intramuscular (i.m.) HSBPA cells, whereas in rats immunized with MC-3 no resistance to a subsequent i.m. challenge could be detected (Eccles and Alexander, 1974b) . However, absense of immunogenicity as defined by graft rejection does not necessarily imply that there is no host reaction to antigens on the membrane of the tumour, and the lymphoid cells in the node draining sarcomata of widely differing immunogenicities displayed comparable tumourspecific cytotoxicity in vitro (Currie and Alexander, 1974) . The finding that the MC-3 evokes a specific host response and yet is not "immunogenic" has been attributed (Alexander, 1974) to its ability to escape destruction by cellmediated immunity by shedding tumour antigens, which pre-empt the attacking cells. If the difference in the extent of the monocytosis produced by the tumours has an immunological basis, then the mechanism must be complex.
Whatever the basis of the tumourinduced monocytosis, there remains the puzzle as to why these monocytes fail to enter sites of inflammation. This also may be linked to immunity and in particular to the presence of immune complexes containing shed tumour-specific antigens in the tissue fluids of tumourbearing rats, the existence of which has been indicated in earlier investigations using these sarcomata (Thomson, Eccles and Alexander, 1973) . We are testing the hypothesis that binding of immune complexes to the Fc receptors of monocytes interferes either directly or by steric hindrance with the membrane recognition of sites involved in extravasation and/or chemotaxis, the processes needed for monocytes to enter sites of inflamnmation and hypersensitivity reactions.
